Case Study – Enrichment of Recombinant Therapeutic Proteins Using SCOPE™ Fractionation
Introduction Daresbury Proteins Ltd specializes in the development and manufacture of complex recombinant proteins for a range of therapeutic and research applications expressed in mammalian cell lines. Some target proteins are secreted at low levels into the cell culture medium making it challenging to purify them away from contaminants. Entropix has developed SCOPE™, a ground-breaking […]